Please assess the completion status of the following clinical trial:

Trial Title: Auricular Acupressure for Chemotherapy-Induced Nausea and Vomiting in Female Breast Cancer Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Adult female patients aged above 18 years old;~* A diagnosis of breast cancer stage I-III;~* Chemotherapy- naive;~* Auricular therapy-naive;~* Be able to communicate in Chinese mandarin;~* Have at least completed a primary school education;~* Agree to participate in the study and be willing to give written informed consent;~* Be scheduled to receive the first cycle of chemotherapy with moderately-high to highly emetogenic potentials;~* Be provided with standard antiemetic medications during chemotherapy.~Exclusion Criteria:~* Extremely weak, disabled or immunocompromised cancer patients;~* Be unable to follow the study instructions to do AT intervention or other research procedures;~* Have concurrent radiotherapy or other kinds of antineoplastic therapy;~* Currently take part in clinical studies on anti-emetic medications or other kinds of non-pharmacological interventions to control CINV, or other studies which are believed to produce potential interactions with this AT trial;~* Have other health problems which may affect the symptoms of CINV such as gastrointestinal disease, liver disease, migraine, tinnitus and Ménière's disease, etc.;~* Ear skin problems which are not appropriate for auricular acupressure including ear infections, ear scars and rashes, ear frostbite, and ear abscess, etc.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- True Auricular Acupressure Group (Type: EXPERIMENTAL): Participants in this group will receive standard antiemetics before and during chemotherapy, and a 5-day auricular acupressure treatment protocol for controlling nausea and vomiting during the first cycle of chemotherapy.
- Sham Auricular Acupressure Group (Type: SHAM_COMPARATOR): Participants in this group will receive standard antiemetic medications before and during chemotherapy, and a 5-day sham auricular acupressure intervention protocol during the first cycle of chemotherapy.
- Standard Care Group (Type: OTHER): Participants in this group will only receive standard anti-emetic treatment before and during chemotherapy.

Based on this trial design, predict the completion outcome and termination type (if applicable).